APA (7th ed.) Citation

Brillanti, S., Mangia, A., Cimino, L., Civolani, A., Fatuzzo, F., Fenoglio, L., . . . Rumi, M. (2003). Re-treatment of interferon (IFN) plus ribavirin (RBV) nonresponders with peginterferon (PEG-IFN) Alfa-2A (40KD) (Pegasys) plus RBV and amantadine (AMA) or IFN Alfa-2A (Roferon-A) plus RBV and AMA. Interim results of a multicenter randomized study. Journal of Hepatology, 38, 129. https://doi.org/10.1016/s0168-8278(03)80708-0

Chicago Style (17th ed.) Citation

Brillanti, S., et al. "Re-treatment of Interferon (IFN) Plus Ribavirin (RBV) Nonresponders with Peginterferon (PEG-IFN) Alfa-2A (40KD) (Pegasys) Plus RBV and Amantadine (AMA) or IFN Alfa-2A (Roferon-A) Plus RBV and AMA. Interim Results of a Multicenter Randomized Study." Journal of Hepatology 38 (2003): 129. https://doi.org/10.1016/s0168-8278(03)80708-0.

MLA (9th ed.) Citation

Brillanti, S., et al. "Re-treatment of Interferon (IFN) Plus Ribavirin (RBV) Nonresponders with Peginterferon (PEG-IFN) Alfa-2A (40KD) (Pegasys) Plus RBV and Amantadine (AMA) or IFN Alfa-2A (Roferon-A) Plus RBV and AMA. Interim Results of a Multicenter Randomized Study." Journal of Hepatology, vol. 38, 2003, p. 129, https://doi.org/10.1016/s0168-8278(03)80708-0.